Monitoring of the anticoagulant effects of a continuous 6-hour infusion of PEG-Hirudin in healthy volunteers using the ecarin clotting time

被引：0
|
作者：
Haas, S
Dubbers, K
Maurer, R
Esslinger, HU
机构：
[1] TECH UNIV MUNICH,INST EXPT SURG,D-8000 MUNICH,GERMANY
[2] KNOLL AG,DEPT HUMAN PHARMACOL,D-6700 LUDWIGSHAFEN,GERMANY
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：P1142 / P1142
页数：2
相关论文
共 17 条
  • [1] Monitoring of the anticoagulant effects of PEG-Hirudin administered as a continuous 24-hour infusion following an i.v. bolus injection in healthy volunteers using the ecarin clotting time
    Esslinger, HU
    Dubbers, K
    Radziwon, P
    Breddin, HK
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1135 - P1135
  • [2] Monitoring of the anticoagulant effects of combined (overlapping) treatment of PEG-Hirudin and heparin using the ecarin clotting time
    Esslinger, HU
    Huhle, G
    Kessler, M
    Dubbers, K
    Malsch, R
    Piazolo, L
    Harenberg, J
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1138 - P1138
  • [3] Ecarin time superior to aPTT in monitoring PEG-hirudin effects.
    Velagapudi, R
    Badimon, JJ
    Kyrle, P
    Sujatta, M
    Bodnar, J
    Faulkner, R
    Fettner, S
    Hull, W
    Cheesbro, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 194 - 194
  • [4] Ecarin clotting time but not aPTT correlates with PEG-Hirudin plasma activity
    Moser, M
    Ruef, J
    Peter, K
    Kohler, B
    Gulba, DC
    Paterna, N
    Nordt, T
    Kübler, W
    Bode, C
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2001, 12 (02) : 165 - 169
  • [5] Ecarin Clotting Time but not aPTT Correlates with PEG-Hirudin Plasma Activity
    Martin Moser MD
    Johannes Ruef MD
    Karlheinz Peter MD
    Benedikt Kohler MD
    Dietrich C. Gulba MD
    Natascha Paterna MD
    Thomas Nordt MD
    Wolfgang Ku¨bler MD
    Christoph Bode MD
    Journal of Thrombosis and Thrombolysis, 2001, 12 : 165 - 169
  • [6] Superior performance of ecarin clotting time over APTT for the monitoring of PEG-hirudin activity in plasma.
    Haas, S
    Esslinger, HU
    Rubsamen, K
    Jeske, WP
    Walenga, JM
    BLOOD, 1997, 90 (10) : 3225 - 3225
  • [7] Effects of PEG-Hirudin in clotting parameters and platelet function and its interaction with aspirin in healthy volunteers
    Esslinger, HU
    Köhne, S
    Radziwon, P
    Walenga, JM
    Breddin, HK
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2003, 9 (01) : 79 - 88
  • [8] The use of PEG-Hirudin in chronic hemodialysis monitored by the Ecarin Clotting Time:: influence on clotting of the extracorporeal system and hemostatic parameters
    Ulbricht, K
    Bucha, E
    Pöschel, KA
    Stein, G
    Wolf, G
    Nowak, G
    CLINICAL NEPHROLOGY, 2006, 65 (03) : 180 - 190
  • [9] A modified ecarin clotting time test monitors the anticoagulant effects of hirudin
    Gandhi, A
    Kristol, D
    Spillert, CR
    PROCEEDINGS OF THE IEEE 25TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, 1999, : 100 - 101
  • [10] The ecarin clotting time but not the aPTT is a reliable indicator for PEG-hirudin blood levels in patients with unstable angina pectoris
    Bode, C
    Kohler, B
    Steg, G
    Parow, C
    Rubsamen, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 3343 - 3343
12